大缺血核心患者血管内取栓与单纯药物治疗的结局比较
该研究为SELECT试验预设二次分析,纳入105例大缺血核心的前循环大血管闭塞患者,比较血管内取栓联合药物治疗与单纯药物治疗的90天结局。结果显示取栓组功能独立比例更高(31% vs 14%),功能结局更好,梗死增长更小,但核心体积每增加10 cm³或治疗每延迟1小时,功能独立几率分别降低42%和40%。
要点
- 大缺血核心患者取栓联合药物治疗较单纯药物治疗功能独立比例更高(31% vs 14%)。
- 取栓组梗死增长更小(44 vs 98 mL),最终梗死体积更小(97 vs 190 mL)。
- 核心体积每增加10 cm³,功能独立几率降低42%;治疗每延迟1小时降低40%。
核心结论
- 大缺血核心患者接受取栓的获益随核心体积增大和治疗延迟而显著下降,但数据提示潜在获益,需随机临床试验验证。
研究设计与样本
- SELECT试验预设二次分析,前瞻性队列研究,纳入9家美国综合卒中中心2016年1月至2018年2月收治的患者,随访90天。
- 共纳入105例大缺血核心患者,其中CT ASPECTS≤5者71例(取栓37例,单纯药物34例),CT灌注核心≥50 cm³者74例(取栓39例,单纯药物35例),两者均大核心者40例(取栓14例,单纯药物26例)。
主要发现
- 10例核心体积>100 cm³接受取栓的患者中,无一例获得良好结局。
关键数值与推荐
- 大缺血核心定义:CT ASPECTS<6或CT灌注相对脑血流量<30%的区域体积≥50 cm³。
- 功能独立定义:90天mRS评分0-2。
临床怎么用
- 对于前循环大血管闭塞伴大缺血核心患者,取栓联合药物治疗可能改善功能结局,但需权衡核心体积和治疗时间。
- 核心体积>100 cm³或治疗延迟较长时,取栓获益明显降低,应个体化决策。
局限性
- 本研究为前瞻性队列的二次分析,非随机对照,存在选择偏倚可能。
- 样本量较小(105例),尤其核心体积>100 cm³亚组仅10例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The efficacy and safety of endovascular thrombectomy (EVT) in patients with large ischemic cores remains unknown, to our knowledge. OBJECTIVE: To compare outcomes in patients with large ischemic cores treated with EVT and medical management vs medical management alone. DESIGN, SETTING, AND PARTICIPANTS: This prespecified analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) trial, a prospective cohort study of imaging selection that was conducted in 9 US comprehensive stroke centers, enrolled patients between January 2016 and February 2018, and followed them up for 90 days. Patients with moderate to severe stroke and anterior circulation large-vessel occlusion presenting up to 24 hours from the time they were last known to be well were eligible for the cohort. Of these, patients with large ischemic cores on computed tomography (CT) (Alberta Stroke Program Early CT Score <6) or CT perfusion scanning (a volume with a relative cerebral blood flow <30% of ≥50 cm3) were included in analyses. EXPOSURES: Endovascular thrombectomy with medical management (MM) or MM only. MAIN OUTCOMES AND MEASURES: Functional outcomes at 90 days per modified Rankin scale; safety outcomes (mortality, symptomatic intracerebral hemorrhage, and neurological worsening). RESULTS: A total of 105 patients with large ischemic cores on either CT or CT perfusion images were included: 71 with Alberta Stroke Program Early CT Scores of 5 or less (EVT, 37; MM, 34), 74 with cores of 50 cm3 or greater on CT perfusion images (EVT, 39; MM, 35), and 40 who had large cores on both CT and CT perfusion images (EVT, 14; MM, 26). The median (interquartile range) age was 66 (60-75) years; 45 patients (43%) were female. Nineteen of 62 patients (31%) who were treated with EVT achieved functional independence (modified Rankin Scale scores, 0-2) vs 6 of 43 patients (14%) treated with MM only (odds ratio [OR], 3.27 [95% CI, 1.11-9.62]; P = .03). Also, EVT was associated with better functional outcomes (common OR, 2.12 [95% CI, 1.05-4.31]; P = .04), less infarct growth (44 vs 98 mL; P = .006), and smaller final infarct volume (97 vs 190 mL; P = .001) than MM. In the odds of functional independence, there was a 42% reduction per 10-cm3 increase in core volume (adjusted OR, 0.58 [95% CI, 0.39-0.87]; P = .007) and a 40% reduction per hour of treatment delay (adjusted OR, 0.60 [95% CI, 0.36-0.99]; P = .045). Of 10 patients who had EVT with core volumes greater than 100 cm3, none had a favorable outcome. CONCLUSIONS AND RELEVANCE: Although the odds of good outcomes for patients with large cores who receive EVT markedly decline with increasing core size and time to treatment, these data suggest potential benefits. Randomized clinical trials are needed.
引用
- Sarraj A, Hassan AE, Savitz S, et al. Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study. JAMA Neurol. 2019. PMID: 31355873. doi:10.1001/jamaneurol.2019.2109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。